Pay in 4 interest-free payments of $6.73 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Introduction Cagrilintide is a long-acting, acylated analog of human amylin developed by Novo Nordisk and investigated as an amylin- and calcitonin-receptor agonist
Animal data suggest subcutaneous routes required substantially higher doses than intravenous in rabbits, 1 mg/kg subcutaneous versus 25 mcg/kg IV, a 40-fold difference
Replace bracketed sections with your specific information
It is designed to be easily absorbed into the bloodstream, offering a convenient and needle-free option for researchers who prefer non-invasive administration
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
US$ 21.80
US$ 25.31
US$ 20.64
US$ 25.37
